Arch Accounts Payable vs Net Receivables Analysis

ARCH Stock  CAD 1.77  0.05  2.91%   
Arch Biopartners financial indicator trend analysis is way more than just evaluating Arch Biopartners prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arch Biopartners is a good investment. Please check the relationship between Arch Biopartners Accounts Payable and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Accounts Payable vs Net Receivables

Accounts Payable vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arch Biopartners Accounts Payable account and Net Receivables. At this time, the significance of the direction appears to have strong relationship.
The correlation between Arch Biopartners' Accounts Payable and Net Receivables is 0.64. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Arch Biopartners, assuming nothing else is changed. The correlation between historical values of Arch Biopartners' Accounts Payable and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Arch Biopartners are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Accounts Payable i.e., Arch Biopartners' Accounts Payable and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.64
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Arch Biopartners obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Arch Biopartners are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Net Receivables

Most indicators from Arch Biopartners' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arch Biopartners current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arch Biopartners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Selling General Administrative is likely to climb to about 763.7 K in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 109.4 K in 2024.
 2021 2022 2023 2024 (projected)
Research Development1.3M2.2M2.5M2.7M
Interest Expense309.3K358.9K412.8K433.4K

Arch Biopartners fundamental ratios Correlations

0.320.45-0.570.150.66-0.60.730.450.450.360.030.560.640.94-0.130.580.650.920.40.590.260.55-0.050.4-0.61
0.320.2-0.270.030.3-0.170.29-0.04-0.040.010.020.160.270.3-0.030.190.280.40.110.320.780.08-0.010.11-0.27
0.450.2-0.850.270.87-0.790.360.80.80.30.020.840.910.65-0.220.690.890.320.950.140.490.63-0.750.95-0.78
-0.57-0.27-0.85-0.33-0.970.97-0.69-0.77-0.77-0.5-0.25-0.92-0.97-0.690.3-0.9-0.97-0.39-0.88-0.58-0.43-0.820.46-0.880.99
0.150.030.27-0.330.32-0.490.130.440.440.90.120.030.320.31-0.990.310.340.120.340.24-0.250.72-0.180.3-0.32
0.660.30.87-0.970.32-0.940.70.760.760.460.230.910.990.8-0.290.91.00.530.880.590.440.78-0.550.88-0.96
-0.6-0.17-0.790.97-0.49-0.94-0.69-0.8-0.8-0.66-0.21-0.87-0.94-0.720.47-0.9-0.94-0.41-0.85-0.61-0.26-0.910.4-0.840.97
0.730.290.36-0.690.130.7-0.690.420.420.350.170.660.680.71-0.120.690.680.640.390.880.280.58-0.080.39-0.77
0.45-0.040.8-0.770.440.76-0.80.421.00.480.130.740.820.64-0.40.780.810.190.870.330.170.72-0.620.87-0.73
0.45-0.040.8-0.770.440.76-0.80.421.00.480.130.740.820.64-0.40.780.810.190.870.330.170.72-0.620.87-0.73
0.360.010.3-0.50.90.46-0.660.350.480.480.20.230.440.42-0.870.480.470.240.390.42-0.210.890.010.36-0.51
0.030.020.02-0.250.120.23-0.210.170.130.130.20.140.20.05-0.120.370.22-0.020.190.43-0.260.19-0.020.19-0.25
0.560.160.84-0.920.030.91-0.870.660.740.740.230.140.920.660.00.870.910.370.870.470.450.63-0.510.88-0.91
0.640.270.91-0.970.320.99-0.940.680.820.820.440.20.920.8-0.290.891.00.490.920.540.440.77-0.610.92-0.95
0.940.30.65-0.690.310.8-0.720.710.640.640.420.050.660.8-0.290.690.80.870.610.570.280.64-0.370.61-0.7
-0.13-0.03-0.220.3-0.99-0.290.47-0.12-0.4-0.4-0.87-0.120.0-0.29-0.29-0.29-0.31-0.12-0.3-0.260.27-0.680.16-0.260.29
0.580.190.69-0.90.310.9-0.90.690.780.780.480.370.870.890.69-0.290.910.390.830.710.230.77-0.450.83-0.9
0.650.280.89-0.970.341.0-0.940.680.810.810.470.220.911.00.8-0.310.910.50.910.570.430.79-0.580.9-0.96
0.920.40.32-0.390.120.53-0.410.640.190.190.24-0.020.370.490.87-0.120.390.50.220.520.250.37-0.060.22-0.43
0.40.110.95-0.880.340.88-0.850.390.870.870.390.190.870.920.61-0.30.830.910.220.260.340.7-0.741.0-0.81
0.590.320.14-0.580.240.59-0.610.880.330.330.420.430.470.540.57-0.260.710.570.520.260.090.540.020.25-0.67
0.260.780.49-0.43-0.250.44-0.260.280.170.17-0.21-0.260.450.440.280.270.230.430.250.340.090.06-0.260.36-0.41
0.550.080.63-0.820.720.78-0.910.580.720.720.890.190.630.770.64-0.680.770.790.370.70.540.06-0.230.68-0.82
-0.05-0.01-0.750.46-0.18-0.550.4-0.08-0.62-0.620.01-0.02-0.51-0.61-0.370.16-0.45-0.58-0.06-0.740.02-0.26-0.23-0.740.38
0.40.110.95-0.880.30.88-0.840.390.870.870.360.190.880.920.61-0.260.830.90.221.00.250.360.68-0.74-0.81
-0.61-0.27-0.780.99-0.32-0.960.97-0.77-0.73-0.73-0.51-0.25-0.91-0.95-0.70.29-0.9-0.96-0.43-0.81-0.67-0.41-0.820.38-0.81
Click cells to compare fundamentals

Arch Biopartners Account Relationship Matchups

Arch Biopartners fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets741.3K2.7M621.6K1.2M1.1M588.8K
Other Current Liab269.8K424.8K190K172.5K155.3K160.5K
Total Current Liabilities1.2M3.2M2.8M6.0M6.9M7.2M
Total Stockholder Equity(3.9M)(3.9M)(4.5M)(5.5M)(5.0M)(4.7M)
Net Debt2.7M4.7M3.9M4.2M4.8M5.1M
Retained Earnings(22.1M)(23.3M)(24.7M)(28.1M)(25.2M)(24.0M)
Accounts Payable949.2K962.0K489.4K393.4K452.4K410.7K
Cash653.7K448.2K506.3K831.3K956.0K1.0M
Cash And Short Term Investments653.7K448.2K506.3K831.3K956.0K1.0M
Common Stock Shares Outstanding59.9M61.3M62.2M62.5M71.8M41.8M
Liabilities And Stockholders Equity741.3K2.7M621.6K1.2M1.1M588.8K
Other Current Assets26.6K19.3K28.1K43.0K49.5K39.8K
Other Stockholder Equity4.6M4.7M4.7M6.7M6.0M6.3M
Total Liab4.6M6.6M5.1M6.7M7.7M8.1M
Total Current Assets741.3K2.7M621.6K1.2M1.3M1.4M
Short Long Term Debt Total3.4M5.2M4.4M5.0M5.8M6.1M
Net Receivables61.0K2.2M87.2K296.9K341.4K337.1K
Non Current Liabilities Total3.4M3.4M2.3M703.9K809.5K1.3M
Common Stock13.7M14.8M15.6M15.9M18.3M11.4M
Net Tangible Assets(2.6M)(3.9M)(3.9M)(4.5M)(4.0M)(3.8M)
Long Term Debt3.4M3.4M2.3M703.9K809.5K769.0K
Net Invested Capital(477.7K)1.3M(57.8K)(493.6K)(444.3K)(422.1K)
Net Working Capital(477.7K)(520.8K)(2.2M)(4.8M)(4.3M)(4.1M)
Capital Stock13.7M14.8M15.6M15.9M18.3M15.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arch Stock Analysis

When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.